Logo image of EVOP

EVO PAYMENTS INC-CLASS A (EVOP) Stock Fundamental Analysis

USA - NASDAQ:EVOP - US26927E1047 - Common Stock

33.99 USD
+0.13 (+0.38%)
Last: 3/23/2023, 8:00:02 PM
33.98 USD
-0.01 (-0.03%)
After Hours: 3/23/2023, 8:00:02 PM
Fundamental Rating

3

EVOP gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 99 industry peers in the Financial Services industry. While EVOP is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, EVOP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year EVOP has reported negative net income.
In the past year EVOP had a positive cash flow from operations.
EVOP had negative earnings in each of the past 5 years.
In the past 5 years EVOP always reported a positive cash flow from operatings.
EVOP Yearly Net Income VS EBIT VS OCF VS FCFEVOP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M -50M 100M 150M 200M

1.2 Ratios

The profitability ratios for EVOP are negative, so there is not much use analyzing them.
EVOP has a better Return On Invested Capital (3.67%) than 65.63% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EVOP is significantly above the industry average of 8.14%.
The 3 year average ROIC (23.91%) for EVOP is well above the current ROIC(3.67%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 3.67%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)23.91%
ROIC(5y)N/A
EVOP Yearly ROA, ROE, ROICEVOP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 10 -10 20 -20 30

1.3 Margins

The Operating Margin of EVOP (12.33%) is better than 61.46% of its industry peers.
EVOP's Operating Margin has improved in the last couple of years.
EVOP has a better Gross Margin (83.54%) than 94.79% of its industry peers.
In the last couple of years the Gross Margin of EVOP has grown nicely.
Industry RankSector Rank
OM 12.33%
PM (TTM) N/A
GM 83.54%
OM growth 3Y26.78%
OM growth 5Y6.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.39%
GM growth 5Y4.38%
EVOP Yearly Profit, Operating, Gross MarginsEVOP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 20 40 60 80

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EVOP is creating value.
EVOP has more shares outstanding than it did 1 year ago.
EVOP has a better debt/assets ratio than last year.
EVOP Yearly Shares OutstandingEVOP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
EVOP Yearly Total Debt VS Total AssetsEVOP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B 2B

2.2 Solvency

EVOP has an Altman-Z score of 0.14. This is a bad value and indicates that EVOP is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.14, EVOP is doing worse than 62.50% of the companies in the same industry.
The Debt to FCF ratio of EVOP is 6.22, which is on the high side as it means it would take EVOP, 6.22 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of EVOP (6.22) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.22
Altman-Z 0.14
ROIC/WACC0.5
WACC7.27%
EVOP Yearly LT Debt VS Equity VS FCFEVOP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 500M -500M

2.3 Liquidity

EVOP has a Current Ratio of 1.11. This is a normal value and indicates that EVOP is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.11, EVOP perfoms like the industry average, outperforming 43.75% of the companies in the same industry.
EVOP has a Quick Ratio of 1.10. This is a normal value and indicates that EVOP is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of EVOP (1.10) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.1
EVOP Yearly Current Assets VS Current LiabilitesEVOP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

EVOP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -289.17%.
Looking at the last year, EVOP shows a quite strong growth in Revenue. The Revenue has grown by 9.35% in the last year.
The Revenue has been growing slightly by 1.47% on average over the past years.
EPS 1Y (TTM)-289.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-442.51%
Revenue 1Y (TTM)9.35%
Revenue growth 3Y3.79%
Revenue growth 5Y1.47%
Sales Q2Q%4.98%

3.2 Future

Based on estimates for the next years, EVOP will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.23% on average per year.
The Revenue is expected to grow by 12.43% on average over the next years. This is quite good.
EPS Next Y11.11%
EPS Next 2Y13.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.83%
Revenue Next 2Y12.43%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EVOP Yearly Revenue VS EstimatesEVOP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
EVOP Yearly EPS VS EstimatesEVOP Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EVOP. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 25.63, EVOP can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EVOP is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.46, EVOP is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 25.63
EVOP Price Earnings VS Forward Price EarningsEVOP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EVOP indicates a somewhat cheap valuation: EVOP is cheaper than 66.67% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EVOP is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 15.94
EV/EBITDA 12.75
EVOP Per share dataEVOP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 -20 -30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EVOP does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as EVOP's earnings are expected to grow with 13.23% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.23%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

EVOP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EVO PAYMENTS INC-CLASS A

NASDAQ:EVOP (3/23/2023, 8:00:02 PM)

After market: 33.98 -0.01 (-0.03%)

33.99

+0.13 (+0.38%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-23 2023-02-23
Earnings (Next)05-02 2023-05-02
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.62%
Ins Owner ChangeN/A
Market Cap1.65B
Revenue(TTM)543.08M
Net Income(TTM)-5.25M
Analysts43.33
Price Target34.68 (2.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.16%
Min EPS beat(2)6.16%
Max EPS beat(2)6.16%
EPS beat(4)3
Avg EPS beat(4)9.16%
Min EPS beat(4)6.16%
Max EPS beat(4)12.28%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.42%
Min Revenue beat(2)-7.71%
Max Revenue beat(2)-7.13%
Revenue beat(4)1
Avg Revenue beat(4)-3.95%
Min Revenue beat(4)-7.71%
Max Revenue beat(4)1.34%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)5.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.63
P/S 3.03
P/FCF 15.94
P/OCF 10.09
P/B N/A
P/tB N/A
EV/EBITDA 12.75
EPS(TTM)-0.11
EYN/A
EPS(NY)1.33
Fwd EY3.9%
FCF(TTM)2.13
FCFY6.27%
OCF(TTM)3.37
OCFY9.91%
SpS11.21
BVpS-15.73
TBVpS-34.62
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 3.67%
ROICexc 4.87%
ROICexgc 30.94%
OM 12.33%
PM (TTM) N/A
GM 83.54%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)23.91%
ROIC(5y)N/A
ROICexc(3y)4.71%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y31.27%
ROICexgc growth 5YN/A
ROICexc growth 3Y19.13%
ROICexc growth 5Y-5.52%
OM growth 3Y26.78%
OM growth 5Y6.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.39%
GM growth 5Y4.38%
F-Score3
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.22
Debt/EBITDA 4.25
Cap/Depr 71.1%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 1.1
Altman-Z 0.14
F-Score3
WACC7.27%
ROIC/WACC0.5
Cap/Depr(3y)56.66%
Cap/Depr(5y)59.66%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-289.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-442.51%
EPS Next Y11.11%
EPS Next 2Y13.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.35%
Revenue growth 3Y3.79%
Revenue growth 5Y1.47%
Sales Q2Q%4.98%
Revenue Next Year12.83%
Revenue Next 2Y12.43%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.13%
EBIT growth 3Y31.58%
EBIT growth 5Y8.18%
EBIT Next Year161.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y116.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.41%
OCF growth 3Y80.13%
OCF growth 5Y81.85%

EVO PAYMENTS INC-CLASS A / EVOP FAQ

What is the fundamental rating for EVOP stock?

ChartMill assigns a fundamental rating of 2 / 10 to EVOP.


Can you provide the valuation status for EVO PAYMENTS INC-CLASS A?

ChartMill assigns a valuation rating of 1 / 10 to EVO PAYMENTS INC-CLASS A (EVOP). This can be considered as Overvalued.


How profitable is EVO PAYMENTS INC-CLASS A (EVOP) stock?

EVO PAYMENTS INC-CLASS A (EVOP) has a profitability rating of 1 / 10.


How financially healthy is EVO PAYMENTS INC-CLASS A?

The financial health rating of EVO PAYMENTS INC-CLASS A (EVOP) is 2 / 10.